After identification of 2,472 cells from 8 BRCA patients using single-cell SRP114962 cohort, we found that CCL19 was mainly expressed in CD8+ T cells, and CD8+ T cell highly cover the tumor (Supplementary Figure 3). Here, CCL19 is linked to neoplasm.